CHICAGO, Oct. 28, 2016 -- The board of directors of GATX Corporation (NYSE:GATX) declared a quarterly dividend of $0.40 per common share, payable December 31, 2016, to shareholders of record on December 15, 2016. This quarterly dividend is unchanged from the prior quarter.
COMPANY DESCRIPTION
GATX Corporation (NYSE:GATX) strives to be recognized as the finest railcar leasing company in the world by its customers, its shareholders, its employees and the communities where it operates. As the largest global railcar lessor, GATX has been providing quality railcars and services to its customers for more than 118 years. GATX has been headquartered in Chicago, Illinois, since its founding in 1898. For more information, please visit the Company's website at www.gatx.com.
Investor, corporate, financial, historical financial, photographic and news release information may be found at www.gatx.com.
FOR FURTHER INFORMATION CONTACT: Christopher LaHurd Director, Investor Relations GATX Corporation 312-621-6228 [email protected]


Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
Boeing Wins $2.04B U.S. Air Force Contract for B-52 Engine Replacement Program
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge
Nvidia to Acquire Groq in $20 Billion Deal to Boost AI Chip Dominance
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing
FDA Approves Mitapivat for Anemia in Thalassemia Patients
BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Hyundai Recalls Over 51,000 Vehicles in the U.S. Due to Fire Risk From Trailer Wiring Issue
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio 



